Martin Puhr

Epithelial-to-Mesenchymal Transition Leads to Docetaxel Resistance in Prostate Cancer and Is Mediated by Reduced Expression of miR-200c and miR-205

Martin Puhr, Julia Hoefer, Georg Schäfer et al. · American Journal Of Pathology · 2012 · 261 citations · Full text

Medicine, Cancer Biology, Oncology +17

ZEB1‐associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat

Simone Meidhof, Simone Brabletz, Waltraut Lehmann et al. · EMBO Molecular Medicine · 2015 · 230 citations · Full text

Medicine, Oncology, Pharmacology +17

The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy

Martin Puhr, Julia Hoefer, Andrea Eigentler et al. · Clinical Cancer Research · 2017 · 170 citations · Full text

Medicine, Oncology, Pharmacology +16

Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells

Luigi Ippolito, Alberto Marini, Lorenzo Cavallini et al. · Oncotarget · 2016 · 145 citations · Full text

Life Sciences, Biochemistry, Oncology +17

Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo

Lei Gu, Paraskevi Vogiatzi, Martin Puhr et al. · Endocrine Related Cancer · 2010 · 124 citations · Full text

Medicine, Molecular Biology, Oncology +16